AI Can Spot Polyps Better Than Doctors During Colonoscopy—But There's a Catch

Artificial intelligence is getting better at spotting dangerous polyps during colonoscopies than doctors working by themselves. A major analysis of 146 studies found that AI detected abnormalities with significantly higher sensitivity—meaning it caught more of what it was looking for—compared to unassisted healthcare professionals. But the real breakthrough isn't AI replacing your gastroenterologist. It's AI working alongside doctors, which boosted detection accuracy even further.

How Much Better Is AI at Finding Polyps?

Researchers conducted a systematic review and meta-analysis examining how artificial intelligence performs in analyzing videos from surgical and interventional procedures, including colonoscopies used to screen for colorectal cancer. The findings were striking: AI showed a relative risk of 1.12 when compared to unassisted healthcare professionals, meaning AI had approximately 12% greater sensitivity in detecting abnormalities. In practical terms, this means AI caught more polyps and suspicious lesions that doctors might have missed on their own.

When it came to specificity—the ability to correctly identify what is normal tissue and avoid false alarms—AI performed comparably to doctors, with no statistically significant difference. This is important because it means AI isn't triggering unnecessary biopsies or causing alarm over benign findings.

The Real Game-Changer: AI as a Helper, Not a Replacement

Here's where the story gets interesting. The study found that when doctors used AI as an assistive tool—essentially having AI flag potential problems for them to review—the results were dramatically better than either AI or doctors working alone. AI-assisted healthcare professionals showed a relative risk of 1.18 for sensitivity and 1.05 for specificity compared to unassisted professionals. That means doctors with AI support caught more polyps and maintained excellent accuracy in avoiding false positives.

Even more compelling: expert doctors working with AI assistance performed just as well as AI working independently, with no meaningful difference in detection rates. This suggests that the future of colorectal cancer screening isn't about replacing experienced gastroenterologists—it's about giving them a technological partner that helps them catch what the human eye might miss during a lengthy, demanding procedure.

Why This Matters for Your Screening

Colorectal cancer remains one of the leading causes of cancer-related deaths in the United States, yet many cases could be prevented or caught early through screening. Colonoscopy is considered the gold standard for detecting precancerous polyps, but the procedure's effectiveness depends heavily on the skill and attention of the person performing it. Fatigue, time pressure, and the sheer volume of procedures can affect detection rates.

The research examined studies that evaluated AI across multiple types of gastrointestinal procedures, including analysis of narrow-band imaging during colonoscopy and automated systems for identifying small colorectal lesions. One notable study found that deep learning systems could localize and identify polyps in real time with 96% accuracy during screening colonoscopies.

Steps to Understanding AI-Assisted Colonoscopy

• Current Reality: Most colonoscopies today are performed without AI assistance, meaning doctors rely entirely on their own visual assessment and experience to spot polyps and suspicious tissue.
• Emerging Technology: AI systems are being integrated into endoscopy equipment to flag potential polyps in real time, allowing doctors to review flagged areas more carefully before moving forward.
• Future Integration: As this technology becomes more widely available, expect AI-assisted colonoscopy to become standard practice at major medical centers, similar to how AI now assists in reading mammograms and CT scans.

The research also examined how AI performed across different expertise levels. Interestingly, AI assistance benefited doctors at all skill levels—not just less experienced practitioners. This suggests that even highly trained gastroenterologists can benefit from an extra set of digital eyes, particularly during longer procedures when attention naturally wanes.

What Experts Say About the Future

The systematic review noted an important gap in current research: most studies to date have evaluated AI head-to-head against unassisted healthcare professionals, but fewer have examined AI as an assistive tool, despite the fact that real-world integration of AI more likely involves assistance than autonomy. This means we're still in the early stages of understanding how to best deploy this technology in clinical practice.

The implications are significant for colorectal cancer screening programs. If AI-assisted colonoscopy can reliably improve polyp detection rates across all experience levels, it could reduce the number of interval cancers—cancers that develop between screening procedures—and improve overall survival rates for colorectal cancer patients. This is particularly important for populations that have historically faced barriers to quality screening or follow-up care.

As healthcare systems consider adopting AI-assisted endoscopy, the evidence suggests the technology works best not as a replacement for experienced doctors, but as a collaborative tool that enhances human expertise. Your next colonoscopy might not look dramatically different, but behind the scenes, the technology helping your doctor spot dangerous polyps is becoming smarter and more reliable.